In the adaptive immune response pathway, PD-L1 is upregulated by IFN-γ.40 When TILs encounter a tumour antigen, they secrete IFN-γ, which leads to PD-L1 upregulation on tumour cells and surrounding immune cells. The gene discussed is IFNG; the disease is neoplasm.